Date published: 2026-1-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR1D4 Inhibitors

OR1D4 inhibitors are a specialized class of chemical compounds that target and inhibit the activity of the OR1D4 receptor, which belongs to the olfactory receptor family. These receptors are G-protein coupled receptors (GPCRs), which play a crucial role in detecting odorants and translating chemical signals into electrical ones that can be processed by the brain. OR1D4, in particular, is part of a subset of receptors responsible for the molecular recognition of specific volatile compounds. The inhibition of these receptors can interfere with the normal signal transduction pathways by preventing the receptor from binding to its natural ligands. This process involves a highly specific interaction where the inhibitor molecule binds to the active site or another regulatory domain of the receptor, altering its conformation and ultimately reducing or halting its ability to activate associated G-proteins.

At the molecular level, OR1D4 inhibitors are designed with structural features that enable them to precisely interact with the key binding pockets of the receptor. These inhibitors may vary in size, polarity, and electronic distribution, all of which influence their binding affinity and selectivity. Inhibition can be competitive, where the inhibitor mimics the natural ligand, or non-competitive, where the inhibitor binds to an allosteric site on the receptor. Research into OR1D4 inhibition has allowed scientists to explore the broader biochemical mechanisms of olfactory receptors and GPCR function. By analyzing how inhibitors interact with these receptors, researchers gain insight into receptor conformational dynamics, signal transduction modulation, and receptor desensitization processes. Understanding the molecular underpinnings of OR1D4 inhibition can have far-reaching implications for the study of cellular signaling and receptor-ligand interactions across diverse biological systems.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor that can prevent the activation of MAPK/ERK pathway, leading to altered protein expression including OR1D4.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that can disrupt PI3K/AKT signaling, potentially influencing OR1D4 activity if it is regulated by this pathway.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K, potentially altering the phosphorylation status and activity of proteins regulated by the PI3K/AKT pathway like OR1D4.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that can suppress protein synthesis, potentially reducing OR1D4 levels if it is sensitive to mTOR regulation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor that can alter stress response pathways, potentially influencing OR1D4 if it is involved in these responses.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Inhibits CaMKII, which can affect calcium signaling pathways that may regulate OR1D4.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

SERCA inhibitor that disrupts calcium homeostasis, potentially affecting OR1D4 if it relies on calcium signaling.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

PKC inhibitor that can modulate protein kinase C dependent pathways, potentially influencing OR1D4 activity.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor that can affect cytoskeleton organization and cell motility, potentially influencing OR1D4 if it is involved in these processes.

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$47.00
$143.00
$680.00
16
(1)

FGFR inhibitor that can alter growth factor signaling, potentially affecting OR1D4 if it is modulated by FGFR pathways.